Table 3.

Mean Mass Loss (%) of (a) 10 K and (b) 35 K OPF composite formulations.

Formulation	PLL MW (kDa)	PLL Dosage(per hydrogel)	OPF MW(g/mol)	Mean mass loss (%)
Day 1	Day 7	Day 14	Day 28
a.)
10 K Control	––	––	10 K	55.4±0.6a,b	59.0±1.8a	49.6±4.5	60.1±0.4
10 K 50Hi	50	20 µg	10 K	55.9±3.9a	62.0±0.7a	52.4±4.8	62.3±7.9
10 K 50Lo	50	500 ng	10 K	46.7±3.0c	51.4±2.7b	48.3±8.0	63.4±0.8
10 K 225Hi	225	20 µg	10 K	53.7±3.1a,b	51.2±2.3b	52.6±7.8	68.3±1.3
10 K 225Lo	225	500 ng	10 K	49.4±2.4b,c	58.5±4.3a	47.7±2.6	60.3±3.7
b.)
35 K Control	––	––	35 K	46.5±3.3	59.2±1.4a	65.1±1.5	71.7±1.7
35 K 50Hi	50	20 µg	35 K	49.3±13.9	52.5±3.0b	63.0±5.9	68.5±1.9
35 K 50Lo	50	500 ng	35 K	45.0±4.3	56.1±4.8a,b	62.7±0.7	64.3±5.3
35 K 225Hi	225	20 µg	35 K	49.6±2.8	59.7±1.3a	61.7±4.9	66.9±6.4
35 K 225Lo	225	500 ng	35 K	52.1±6.4	55.0±2.4a,b	55.4±7.6	67.4±7.0

For each time point, values not connected by the same letters (a, b, or c) are significantly different (p<0.05).